Diamyd Medical

Contact
diamyd.com
+468-6610026

Diamyd Medical AB

Linnégatan 89 B
115 23 Stockholm
Sweden
+468-6610026
diamyd.com
Contact
Profile News
Contact

About Diamyd Medical

Diamyd Medical is a life science company developing treatments for diabetes and its complications. The company’s furthest developed project is the GAD-based drug Diamyd® for autoimmune diabetes for which Phase III studies are planned. Diamyd® has demonstrated significant and positive results in Phase II clinical trials in Sweden.

Read more about Diamyd Medical
Facts about Diamyd Medical
  • Focus : Manufacturer
  • Industry : Pharma

News about Diamyd Medical

Diamyd Medical

27-Nov-2007 | research and development

Diamyd executes agreement with US National Institutes of Health for a type 1 diabetes trial

Diamyd Medical announced that it has executed a Clinical Trial Agreement with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ...

Read news
Diamyd Medical

09-Aug-2006 | business & finance

Diamyd Medical outlicences Gene to Neurologix for treatment of Parkinson's disease

Diamyd Medical AB has entered into a non-exclusive license agreement by which Neurologix, Inc., obtained rights to use the GAD65 molecule in its ...

Read news
Diamyd Medical

22-Dec-2005 | business & finance

Diamyd Medical appoints Protein Sciences for production of its lead therapeutic diabetes vaccine

Diamyd Medical AB announced that is has reached an agreement with Protein Sciences Corporation, a biopharmaceutical service company, for production of ...

Read news
Diamyd Medical

15-Dec-2005 | business & finance

Diamyd Medical broadens diabetes pipeline with acquisition of Nurel Therapeutics

Diamyd Medical AB emerged as a global biotechnology company as shareholders approved the acquisition of Nurel Therapeutics Inc at a General Assembly ...

Read news
Diamyd Medical

24-Nov-2005 | business & finance

Diamyd aquires American biotechnology company Nurel Therapeutics, Inc.

Diamyd Medical AB announced that it has agreed to acquire all of the outstanding shares in Nurel, a Pittsburgh PA-based biotechnology company. The merger ...

Read news
Diamyd Medical

11-Nov-2005 | business & finance

Diamyd Provides Update on Negotiations to Acquire American Biotechnology Company

Diamyd Medical AB announced that it is making considerable progress in the negotiations to acquire a small American biotechnology company. This acquisition ...

Read news
Diamyd Medical

07-Jun-2005 | research and development

Dyamid's GAD gene is a potential therapeutic for reducing pain associated with Diabetes, Neuropathy and Cancer

Diamyd Medical AB reported that the GAD gene can potentially be used for treatment of pain and neuropathy - common complications of diabetes and cancer. ...

Read news
Diamyd Medical

06-Apr-2005 | business & finance

Diamyd assigns Biovitrum development of production process for its diabetes drug GAD65

Diamyd Medical AB and Biovitrum AB have signed an agreement covering the market adaptation of the production process for GAD65, Diamyd's product for the ...

Read news
Show more news about Diamyd Medical

Here you will find Diamyd Medical AB